We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 2,170

Federal Circuit revives certain sham petitioning antitrust counterclaims in Tyco-mutual ANDA litigation

  • Hogan Lovells
  • -
  • USA
  • -
  • August 26 2014

In a split decision, the U.S. Court of Appeals for the Federal Circuit affirmed summary judgment on two antitrust counterclaims brought by Mutual

Will the USPTO respond to public feedback of its eligibility guidance?

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • August 25 2014

Periodically, the USPTO holds open meetings with the public to discuss its thinking on current topics relating to the patent procurement process

B.C. Supreme Court breathes life into new breed of potential pharma-related class action whereby innovator profits are at risk

  • McCarthy Tétrault LLP
  • -
  • Canada
  • -
  • August 22 2014

In Canada, innovator drug companies can protect their market exclusivity from generic copycats by asserting patents against the generic manufacturer

Airing the USPTO’s naturally occurring dirty laundry -- the subject matter eligibility stain

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • August 21 2014

It has been five months since the USPTO issued its Guidance For Determining Subject Matter Eligibility of Claims Reciting Or Involving Laws of Nature

The new proposals for patent law may increase clinical trials conduct

  • Eversheds LLP
  • -
  • European Union, United Kingdom
  • -
  • August 21 2014

The Legislative Reform (Patents) Order 2014 (the "Order") is scheduled to come into force on 1 October 2014 (this may change during Parliamentary

Extended protection for medical devices a hot topic in the United Kingdom

  • Carpmaels & Ransford LLP
  • -
  • United Kingdom
  • -
  • August 20 2014

Manufacturers of medical devices are requesting an increasing number of patent term extensions in a bid to recover the cost of getting regulatory

Prior claiming in Australiahas news of its demise been greatly exaggerated? Is prior claiming still applicable to the remaining 1952 Act pharmaceutical patents?

  • Freehills Patent Attorneys
  • -
  • Australia
  • -
  • August 20 2014

This is one of two related articles on aspects of prior claiming. Our related article concerns the potential application of prior claiming case law

Yamanaka iPSC patent challenged

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • August 20 2014

Dr. Shinya Yamanaka of Kyoto University shared the 2012 Nobel Prize in Physiology or Medicine with Dr. John B. Gurdon for their respective

Australian pharmaceutical patents expiring September 2014 and recent pharma news

  • Phillips Ormonde Fitzpatrick
  • -
  • Australia
  • -
  • August 20 2014

Click here to view the table

Prosecution bar in protective order does not bar outside litigation counsel from participating in an inter partes review proceeding, SDNY rules

  • Paul Hastings LLP
  • -
  • USA
  • -
  • August 18 2014

Last week, the Southern District of New York rejected an attempt by multiple generic defendants to prevent litigation counsel for the innovator